SALT LAKE CITY, UT--(Marketwire - April 15, 2009) - Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that it will release its fiscal 2009 third quarter financial results at the close of market on Monday, May 4, 2009.
The company will host a conference call on Tuesday, May 5, at 10:00 a.m. Eastern to review the financial results. Participating on the call will be: Peter D. Meldrum, President and Chief Executive Officer; Jim Evans, Chief Financial Officer; Gregory C. Critchfield, M.D., President of Myriad Genetic Laboratories, Inc.; and, Adrian N. Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc.
To participate on the call, callers may dial (212) 231-2903 or (800) 768-5109 approximately 10-15 minutes before the start of the call. All callers will be asked to reference reservation number 21421979.
The conference call also will be available to interested parties through a live audio Internet broadcast at www.myriad.com.
A replay of the call will be available beginning two hours after the end of the call until seven days following the call and may be accessed by dialing (800) 633-8284 or (402) 977-9140, and entering the reservation number 21421979.
Myriad Genetics, Inc. is a leading healthcare company focused on the development and marketing of novel molecular diagnostic and therapeutic products. Myriad’s news and other information are available on the company’s Web site at www.myriad.com. MYGN-F
Contact:
Suzanne Barton
Director, Investor Relations
(801) 584-1138
Email Contact
